Serum miR-455-5p and Cardiac Structure and Function Parameters in Patients With Hypertensive Heart Disease
Enrolling by invitationOBSERVATIONAL
Enrollment
46
Participants
Timeline
Start Date
January 1, 2021
Primary Completion Date
June 30, 2025
Study Completion Date
December 31, 2025
Conditions
HypertensionHeart Disease
Trial Locations (1)
Unknown
the University of Hongkong-Shenzhen Hospital, Shenzhen
All Listed Sponsors
lead
The University of Hong Kong-Shenzhen Hospital
OTHER
NCT07033676 - Serum miR-455-5p and Cardiac Structure and Function Parameters in Patients With Hypertensive Heart Disease | Biotech Hunter | Biotech Hunter